In the article in the July 2021 compendium, the following disclosure was missing:
Dr. Schmid-Schonbein owns stock in Palisade Bio, a company to develop shock treatments.
Mazor R, Dos Santos F, Joyce B, et al.: Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock. Crit Care Explor 2021; 3:e0469